Aptus Pharma Ltd

BSE: 544529

₹320.70

up-down-arrow6.25 (1.99%)

As on 28-Aug-2026IST

Market cap

info icon

₹550 Cr

Revenue (TTM)

info icon

₹47 Cr

P/E Ratio

info icon

119.1

P/B Ratio

info icon

16.4

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score8/10

Growth Score fund-quick-summary-circle

Growth Score5/10

Valuation Score fund-quick-summary-circle

Valuation Score7/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

Aptus Pharma Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 320.70 High: 320.70

52 Week Range

Low: 32.32 High: 320.70

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹5 Cr

  • ROEROE information

    30.5 %

  • ROCEROCE information

    30 %

  • Industry P/EIndustry P/E information

    39.9

  • EV/EBITDAEV/EBITDA information

    73.3

  • Debt to EquityDebt to Equity information

    0.3

  • Book ValueBook Value information

    ₹13.6

  • EPSEPS information

    ₹2.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    17,150,000

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aptus Pharma
373.0 28.0 81.7 -- -- -- --
BSE Healthcare
18.8 2.8 8.7 17.1 23.1 14.8 12.4
As on 28-Aug-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Aptus Pharma
320.7 550.0 46.6 4.6 -- 30.5 119.1 16.4
3,281.6 26,870.9 1,461.8 387.4 34.5 25.2 69.6 15.5
813.5 16,000.2 7,784.0 688.5 10.6 14 23.1 2.7
449.9 17,241.8 2,141.5 58.5 5.8 3.3 162.3 4.5
836.7 20,739.4 5,632.3 662.4 17.2 14.3 31.3 4.2
1,532.2 17,579.4 1,543.3 -48.6 3.6 -0.6 -- 3.0
218.7 29,103.3 9,205.3 -371.8 1.7 -3.8 -- 3.6
1,804.4 29,891.8 1,935.8 288.2 20.6 29.8 103.7 22.3
403.4 16,284.0 3,600.2 221.0 9.7 5.6 73.7 3.4
1,977.1 32,103.6 3,564.0 414.0 15.3 8.4 78.5 6.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Aptus Pharma

--

  • Incorporated

    2010

  • Chairman

    --

  • Managing Director

    Tejash Maheshchandra Hathi

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.aptus-pharma.com

FAQs for Aptus Pharma

The share price of Aptus Pharma Ltd is ₹320.70 (BSE) as of 28-Aug-2026 IST. Aptus Pharma Ltd has given a return of --% in the last 1 years.

The P/E ratio of Aptus Pharma Ltd is 119.05 times as on 28-Aug-2026, a 198 premium to its peers’ median range of 39.90 times.
The P/B ratio of Aptus Pharma Ltd is 16.35 times as on 28-Aug-2026, a 284 premium to its peers’ median range of 4.26 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
20.74
10.26
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2026
20.74
10.26

The 52-week high and low of Aptus Pharma Ltd are Rs 320.70 and Rs 32.32 as of 31-Aug-2026.

Aptus Pharma Ltd has a market capitalisation of ₹ 550 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Aptus Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...